Nafithromycin in CABP: promise and precaution-authors' reply
Himanshu Pophale1, Monica Gupta2, Hariharan Periasamy3
1Jeevandhara Multispecialty Hospital, Pune, Maharashtra, India.
The Lancet Regional Health. Southeast Asia
|December 1, 2025
Summary
No abstract available in PubMed .
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
34.0K
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.5K
